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The authors have retracted this article [1] as the fMRI data
presented in the case report are incorrect. The activation
data reported for session 1 are the activation data for
session 2 and vice versa. As a result the discussion and
conclusions of the case report are based on the wrong
set of data and are no longer valid. The authors apologise
for the error.
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